FLR
46
-2
NUE
39
-4
PEG
55
2
APH
62
-3
ACN
45
-4
EW
53
-2
KO
44
-2
EA
50
-2
VTR
43
-3
PLD
43
-2
JPM
59
-3
PNR
66
-3
AAPL
64
11
PVH
60
2
GLW
42
-3
UHS
52
2
NWSA
73
-2
MAR
62
-3
EMR
64
-3
AVB
57
-2
FLR
46
-2
NUE
39
-4
PEG
55
2
APH
62
-3
ACN
45
-4
EW
53
-2
KO
44
-2
EA
50
-2
VTR
43
-3
PLD
43
-2
JPM
59
-3
PNR
66
-3
AAPL
64
11
PVH
60
2
GLW
42
-3
UHS
52
2
NWSA
73
-2
MAR
62
-3
EMR
64
-3
AVB
57
-2
Financhill
Back

Benitec Biopharma 10K Form

Buy
58

BNTC
Benitec Biopharma

Last Price:
11.68
Seasonality Move:
9.51%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-11-13 10Q BNTC/Benitec Biopharma Quarterly
2023-05-15 10Q BNTC/Benitec Biopharma Quarterly
2023-02-13 10Q BNTC/Benitec Biopharma Quarterly
2022-11-10 10Q BNTC/Benitec Biopharma Quarterly
2022-05-16 10Q BNTC/Benitec Biopharma Quarterly
2022-02-14 10Q BNTC/Benitec Biopharma Quarterly

Receive BNTC News And Ratings

See the #1 stock for the next 7 days that we like better than BNTC

BNTC Financial Statistics

Sales & Book Value

Annual Sales: $75K
Cash Flow: $-4.59M
Price / Cash Flow: 0
Annual Sales: $3.59
Price / Book: 4.26

Profitability

EPS (TTM): -5.28930
Net Income (TTM): $-20.86M
Gross Margin: $75K
Return on Equity: 0%
Return on Assets: 0%

Benitec Biopharma Earnings Forecast

Key Benitec Biopharma Financial Ratios

  • The Gross Profit Margin over the past 11 years for BNTC is 100.00%.
  • The Selling, General & Administrative Expenses for BNTC have been equal to 8,509.33% of Gross Profit Margin.
  • The Interest Expense is -0.17% of Operating Income.
  • Per Share Earnings over the last 12 years have been positive in 7 years.

Benitec Biopharma Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: BNTC
CUSIP: 08205P
Website: benitec.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BNTC Technical Analysis vs Fundamental Analysis

Buy
58
Benitec Biopharma (BNTC) is a Buy

Is Benitec Biopharma a Buy or a Sell?

  • Benitec Biopharma stock is rated a Buy
    The current Benitec Biopharma [BNTC] share price is $11.77. The Score for BNTC is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.